Japan's Saitama Medical University International Medical Center Joins TriNetX Network to Study Global Data on Rare Diseases, Treatments, and Outcomes
PR99715
Japan's Saitama Medical University International Medical Center Joins the TriNetX Network to Study Global Real-World Data on Rare Diseases, Treatments, and Outcomes to Benefit Its Patients
CAMBRIDGE, Mass., March 7, 2023 /PRNewswire=KYODO JBN/ --
Saitama Medical University International Medical Center, one of Japan's leading
hospitals for the treatment of oncology, cardiology, and stroke cases, has
joined the TriNetX Network to utilize global real-world data to better
understand rare diseases, treatments, and outcomes, as well as provide
additional clinical trial opportunities to its patients.
Logo – https://mma.prnewswire.com/media/542641/TriNetX_Logo.jpg
"Novel therapies may have unanticipated outcomes across diverse patient
populations," said Isamu Koyama, Hospital Director Emeritus, Saitama Medical
University International Medical Center and Senior Management Director, Saitama
Medical University Foundation. "It is important to share real-world data on
those treatments and outcomes from an international perspective, and that is
precisely what TriNetX brings to the investigators at Saitama Medical
University as well as peer institutions across the TriNetX Network."
TriNetX is the largest and fastest-growing collaborative research network
comprised of healthcare organizations and life sciences companies driving
real-world research to accelerate the development of new therapies. TriNetX
puts the power of real-world data into the hands of its worldwide community to
improve protocol design, streamline trial operations, refine safety signals,
and enrich real-world evidence generation.
"One of the most important values of our health system is patient-centered
care, which always places the interest of patients first," said Toshiaki Saeki,
Director of Saitama Medical University International Medical Center. "TriNetX
is the global leader in the field of secondary use of real-world data for
clinical and observational research and is in the best position to effectively
connect our hospital with other medical institutions and corresponding
real-world data from around the world."
"We are thrilled to welcome Saitama Medical University to the TriNetX Network,"
said Shogo Wakabayashi, Country Manager, Japan, TriNetX, "We look forward to
helping the university's investigators generate real-world evidence and
increase the clinical trial opportunities available for their patients."
About TriNetX, LLC
TriNetX is a global network of healthcare organizations and life sciences
companies driving real-world research to accelerate the development of new
therapies. Through its self-service, HIPAA, GDPR, and LGPD-compliant platform
of federated EHR, datasets, and consulting partnerships, TriNetX puts the power
of real-world data into the hands of its worldwide community to improve
protocol design, streamline trial operations, refine safety signals, and enrich
real-world evidence generation. For more information, visit TriNetX at
www.trinetx.com (
) or follow @TriNetX (
) on Twitter.
About Saitama Medical University International Medical Center
In striving to create a world-class hospital, we have contributed to the
advancement of medical care in Japan while at the same time valuing local
medical care. "Patient-centered care" is the most important value of our
hospital. We believe that the center of health care is always the patient,
his/her family, and the people in the community and society. The hospital has
become one of the leading hospitals in Japan in terms of the number of cases in
all divisions of oncology, cardiology, and stroke. Furthermore, we are actively
working to improve quality, and in February 2015, we became the first
university hospital in Japan to receive JCI (Join Commission International)
certification, an international hospital functionality evaluation, and we
continue to renew this certification. We will continue to tirelessly pursue
improvements in the quality and safety of medical care and aim to be a medical
institution that is trusted by patients and the local community in all
situations, including emergencies such as new coronavirus infections and
large-scale disasters. For more information, visit Saitama Medical University
at https://www.international.saitama-med.ac.jp/en/
Media Contacts
TriNetX, LLC
Bill Stetson
(857) 285-6038
press@trinetx.com
japan@trinetx.com
Saitama Medical University International Medical Center
Hideo Takehisa
take39@saitama-med.ac.jp
SOURCE TriNetX
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。
